# Lin Shen, M.D. – FDA Inspection, Nov 17, 2023

Source: https://www.keypedia.com/records/fda_inspections/lin-shen-md/fdd58e48-c5a8-4c82-a552-cc8b8a1a0c01
Source feed: FDA_Inspections

> FDA inspection 1225051 of Lin Shen, M.D., November 17, 2023. Classification: Official Action Indicated (OAI). 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1225051
- Company Name: Lin Shen, M.D.
- Inspection Date: 2023-11-17
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1316048 - 2026-05-06](https://www.keypedia.com/records/fda_inspections/lin-shen-md/357381eb-cb58-47e9-9a9a-8a8b4a5d3216)
- [FDA Inspection 1158989 - 2021-11-24](https://www.keypedia.com/records/fda_inspections/lin-shen-md/981c8e88-61d0-44a7-9482-9d0ba58a0f06)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/koffi-a-amegadje/817a228e-0003-43d0-bf59-71aeba0fd1f5)

Company: https://www.keypedia.com/companies/lin-shen-md/38ec4e28-dc8d-443d-a07a-09d1c8a4fbf7

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c